CorVel Corporation (CRVL) - 10-K Summary
Business Context and Reporting Period
Company: CorVel Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2004
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation, auto, and group health insurance. Services include automated medical fee auditing, preferred provider networks (PPOs), utilization review, and patient management (case management, vocational rehabilitation). The company operates in one reportable segment: managed care.
Key Financial Metrics (Fiscal Year 2004)
| Metric | Fiscal 2004 | Fiscal 2003 | Change |
|---|---|---|---|
| Revenues | $305.3 million | $282.8 million | +8.0% |
| Cost of Revenues | $253.8 million | $230.9 million | +10.0% |
| Gross Profit | $51.4 million | $51.8 million | -0.8% |
| Gross Margin | 16.8% | 18.3% | -150 bps |
| Net Income | $16.0 million | $16.6 million | -3.4% |
| Diluted EPS | $1.48 | $1.50 | -1.3% |
| Cash & Equivalents | $8.6 million | $5.9 million | +45.8% |
| Working Capital | $41.2 million | $37.5 million | +9.9% |
| Total Debt | $0 | $0 | N/A |
Note: The company had no long-term debt outstanding as of March 31, 2004. It maintained a $5 million line of credit with no borrowings.
Material Changes vs. Prior Period
- Revenue Growth Deceleration: While revenues reached a record $305.3 million, the 8% growth rate was significantly lower than the 20% growth seen in fiscal 2003. Sequential quarterly growth has been slowing, with a 1.5% increase in the final quarter.
- Margin Compression: Gross margin declined from 18.3% to 16.8%. This was primarily driven by the growth of the "CorcareRx" pharmacy service, which has lower margins, and increased costs for IME/MRI providers.
- Expense Management: Despite revenue growth, total expenses increased by $23.9 million (10%), outpacing revenue growth. However, the company reduced field headcount by over 200 employees (excluding acquisitions) to control costs.
- Acquisitions: The company acquired Scan One (document imaging) in June 2003, contributing approximately $2 million to revenue growth in fiscal 2004. No contingent payments were made for the AnciCare acquisition as revenue milestones were not met.
- Stock Repurchases: The company spent $12.2 million to repurchase 342,121 shares in fiscal 2004, reducing the authorized repurchase pool to 526,572 shares remaining.
Guidance, Outlook, and Risks
Management Commentary: Management notes that the market environment is challenging due to declining manufacturing employment, reduced workers' compensation claims, and increased price competition. They emphasize the need to keep cost growth below revenue growth to maintain profitability. The company continues to invest in its "Care MC" web-based platform and proprietary software (MedCheck).
Key Risks:
- Regulatory Changes: Changes in state workers' compensation laws or healthcare reform (e.g., 24-hour coverage proposals) could reduce demand for services.
- Competition: Intense competition from larger insurance carriers, HMOs, and TPAs that may bring services in-house.
- Market Dynamics: A decline in workplace injury rates or a shift toward early intervention services could reduce the volume of claims requiring later-stage management services.
- Staffing: Shortages of qualified nurses and case managers could increase labor costs.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 8% revenue growth given the slowing sequential quarterly trends and the impact of the Scan One acquisition.
- Margin Trends: Monitor the gross margin trajectory, specifically the impact of the low-margin CorcareRx service expansion versus high-margin bill review services.
- Accounts Receivable: Review the Days Sales Outstanding (DSO), which improved to 54 days in 2004 from 56 days in 2003, to ensure collection efficiency remains stable.
- Stock Repurchase Impact: Assess the remaining capacity of the stock repurchase program ($526k shares remaining) and its effect on EPS.
- Regulatory Exposure: Evaluate the specific state-level regulatory changes in the company's top operating regions that could impact fee schedules or managed care mandates.